At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 10 enrolled
Drug / intervention
Dotarem® IV injection at 0.1 mmol/kgdrug
Likely dose
Dotarem® IV injection at 0.1 mmol/kg 0.2 mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Safety and Dialysability of Dotarem® in Dialysed Patients - Phase 1 Clinical Study
In Brief
A Phase 1 clinical trial evaluating Dotarem® IV injection at 0.1 mmol/kg for End-stage Renal Failure. Completed, enrolled 10 participants across 1 site.
Detailed Summary
To evaluate the dialysability of Dotarem®, after an IV injection of 0.1 mmol/kg in patients with chronic renal failure who require hemodialysis treatment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEnd-stage Renal Failure
CountriesBelgium
Collaborators--
Timeline
Phase 1CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedOct 2011
Enrollment StartNov 2011
Primary CompletionMar 2012
Study CompletionJun 2012
TodayJul 2026
First PostedOct 10, 2011
Enrollment StartNov 1, 2011
Primary CompletionMar 1, 2012
Study CompletionJun 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 14.7 years ago
Interventions
Dotarem® IV injection at 0.1 mmol/kgdrug
Dotarem® was IV administered at a dose of 0.1 mmoL/kg (0.2 mL/kg).